Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Lymphomas

Access ESMO scientific and educational resources on Lymphomas
Recent medwireNews and resources from conferences are for ESMO Members only.

International Prognostic Index Tools for Lymphoma

Hasenclever-Index for Hodgkin's Disease

Clinical Practice Guidelines

Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia

05 Oct 2016

Interactive/Pocket Guideline

Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines

01 Sep 2016

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia: ESMO Clinical Practice Guidelines

01 Sep 2016

Interactive/Pocket Guideline

Peripheral T-Cell Lymphomas Peripheral T-Cell Lymphomas: ESMO Clinical Practice Guidelines

27 Aug 2015

Diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) ESMO Consensus Guidelines: Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) and Chronic Lymphocytic Leukemia (CLL)

01 Mar 2013

Interactive/Pocket Guideline

More guidelines

Latest ESMO videos

ESMO Expert Video Report on Diffuse Large B-Cell Lymphoma

03 Jul 2019

ESMO Expert Video Report on standard approaches and new treatment options for DLBCL

17 Dec 2018

Watch all ESMO videos

Featured medwireNews

22 Dec 2021

Anticancer Agents; Lymphomas

Mosunetuzumab offers high response rates in relapsed or refractory follicular lymphoma

21 Dec 2021

Immunotherapy; Lymphomas

Liso-Cel CAR T-Cell Therapy May TRANSFORM Second-Line LBCL Care

17 Dec 2021

Immunotherapy; Lymphomas

Tisagenlecleucel Fails To Extend Aggressive B-Cell Lymphoma Survival

16 Dec 2021

Immunotherapy; Lymphomas

Axi-Cel Extends Relapsed/Refractory Large B-Cell Lymphoma EFS

16 Apr 2021

Anticancer Agents; Lymphomas

Adding Copanlisib To Rituximab Improves PFS In Relapsed Indolent NHL

More news

E-Learning

18 Dec 2019

Haematological Malignancies; Lymphomas

ESMO E-Learning: Open Questions in the Treatment of Follicular Lymphoma

Michele Ghielmini

30 Jul 2018

Haematological Malignancies; Lymphomas

ESMO E-Learning: Mantle Cell Lymphoma

Tobias Weiglein , Martin Heinz Dreyling

04 May 2016

Haematological Malignancies; Imaging; Lymphomas

ESMO E-Learning: The Lugano Classification recommendations for Hodgkin’s and non-Hodgkin’s lymphoma: Staging, Response Assessment and Follow Up

Emanuele Zucca , Francesca Pavanello

More e-learning modules

Meeting resources

09 Dec 2021

In vivo modulation of NKs

Presenter: Marcus Bosenberg

Session: NK cells biology and therapeutic opportunities, innate immunity, adaptive immunity

Resources:

Webcast

09 Oct 2021

HDAC inhibitor romidepsin in cancer

Presenter: Susan Bates

Session: Transcription and translation inhibitors in cancer treatment

Resources:

Slides

Webcast

20 Sep 2021

Invited Discussant 826O and 827O

Presenter: Lena Specht

Session: Proffered Paper session - Haematological malignancies

Resources:

Slides

Webcast

20 Sep 2021

826O - Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial

Presenter: Muhit Özcan

Session: Proffered Paper session - Haematological malignancies

Resources:

Abstract

Slides

Webcast

19 Sep 2021

832MO - Immune microenvironment in classical Hodgkin lymphoma: Composition and dynamics in patients with relapsed/refractory disease

Presenter: Liudmila Fedorova

Session: Mini oral session - Haematological malignancies

Resources:

Abstract

Slides

Webcast

More meeting resources